Chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy

Pathophysiology

Volumn 20, Issue 1, 2013, Pages 59-69

  Fiala, Milan ^a,b   Avagyan, Hripsime ^a,b   Merino, Jose Joaquin ^c   Bernas, Michael ^e   Valdivia, Juan ^d   Espinosa Jeffrey, Araceli ^b   Witte, Marlys ^e   Weinand, Martin ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclooxygenase 2; E2F1; Interleukin 1 ; Medically intractable temporal lobe epilepsy; Neuronal apoptosis; RANTES

Indexed keywords

BETA CHEMOKINE; CASPASE 3; CASPASE 8; CASPASE 9; CD68 ANTIGEN; CELL CYCLE PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLOOXYGENASE 2; FIBRIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; RETINOBLASTOMA PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR E2F1;

ADULT; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; BRAIN TISSUE; CELL NUCLEUS; CHEMOTAXIS; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR SPACE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MITOGENESIS; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TEMPORAL CORTEX; TEMPORAL LOBE EPILEPSY; TRAUMATIC BRAIN INJURY;

EID: 84878167121     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2012.02.003     Document Type: Article

References (68)

1. Henshall D.C., Simon R.P. Epilepsy and apoptosis pathways. J. Cereb. Blood Flow Metab. 2005, 25(12):1557-1572.
2. Henshall D.C., et al. Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ. 2001, 8(12):1169-1181.
3. Meller R., et al. Activation of the caspase 8 pathway mediates seizure-induced cell death in cultured hippocampal neurons. Epilepsy Res. 2006, 70(1):3-14.
4. Yamamoto A., et al. Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsy. Exp. Neurol. 2006, 202(2):410-420.
5. Hallstrom T.C., Nevins J.R. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(19):10848-10853.
6. Nguyen M.D., Mushynski W.E., Julien J.P. Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ. 2002, 9(12):1294-1306.
7. Herrup K., et al. Divide and die: cell cycle events as triggers of nerve cell death. J. Neurosci. 2004, 24(42):9232-9239.
8. Jordan-Sciutto K.L., et al. Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. J. Neurosci. 2002, 22(6):2185-2195.
9. Jordan-Sciutto K., Rhodes J., Bowser R. Altered subcellular distribution of transcriptional regulators in response to Abeta peptide and during Alzheimer's disease. Mech. Ageing Dev. 2001, 123(1):11-20.
10. Ranganathan S., Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol. 2003, 162(3):823-835.
11. Hoglinger G.U., et al. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(9):3585-3590.
12. Jordan-Sciutto K.L., et al. Expression patterns of retinoblastoma protein in Parkinson disease. J. Neuropathol. Exp. Neurol. 2003, 62(1):68-74.
13. Xiao-Ting H., Patrick K. Update and overview of the International League Against Epilepsy consensus definition of drug-resistant epilepsy. Eur. Neurol. Rev. 2011, 6(1):57-59.
14. Schobitz B., De Kloet E.R., Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 1994, 44(4):397-432.
15. Zhao B., Schwartz J.P. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J. Neurosci. Res. 1998, 52(1):7-16.
16. Sheng J.G., et al. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J. Neurochem. 1994, 63(5):1872-1879.
17. De Simoni M.G., et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 2000, 12(7):2623-2633.
18. Vezzani A., Baram T.Z. New roles for interleukin-1 beta in the mechanisms of epilepsy. Epilepsy Curr. 2007, 7(2):45-50.
19. Ravizza T., et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29(1):142-160.
20. Vezzani A., Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46(11):1724-1743.
21. Maijoie H.J., Rijkers K., Berfelo M.W., Hulsman J.A., Myint A., Schwarz M., Vies J.S. Vagus nerve stimulation in refractory epilepsy: effects of pro- and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation 2010, 18(1):52-56.
22. Burkovetskaya M.E., Levin S.G., Godukhin O.V. Neuroprotective effects of interleukin-10 and tumor necrosis factor-alpha against hypoxia-induced hyperexcitability in hippocampal slice neurons. Neurosci. Lett. 2007, 416(3):236-240.
23. Jauneau A.C., et al. Interleukin-1beta and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes. J. Neuroinflammation 2006, 3:8.
24. Murphy P.M., et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52(1):145-176.
25. Valerio A., et al. Gene expression profile activated by the chemokine CCL5/RANTES in human neuronal cells. J. Neurosci. Res. 2004, 78(3):371-382.
26. Pujol F., Kitabgi P., Boudin H. The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J. Cell Sci. 2005, 118(Pt 5):1071-1080.
27. Brandimarti R., et al. Regulation of cell cycle proteins by chemokine receptors: a novel pathway in human immunodeficiency virus neuropathogenesis?. J. Neurovirol. 2004, 10(Suppl. 1):108-112.
28. Shimizu S., et al. Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology. Neurobiol. Dis. 2007, 25(1):17-26.
29. Weinand M.E., Wyler A.R., Richey E.T., Phillips B.B., Somes G.W. Long-term ictal monitoring with subdural strip electrodes: prognostic factors for selecting temporal lobectomy candidates. J. Neurosurg. 1992, 77(1):20-28.
30. Fiala M., et al. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur. J. Clin. Invest. 2002, 32(5):360-371.
31. Fiala M., et al. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12849-12854.
32. Hideshima T., et al. Cytokines and signal transduction. Best Pract. Res. Clin. Haematol. 2005, 18(4):509-524.
33. Babcock A.A., et al. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 2003, 23(21):7922-7930.
34. Gortz A., et al. The chemokine ESkine/CCL27 displays novel modes of intracrine and paracrine function. J. Immunol. 2002, 169(3):1387-1394.
35. Foresti M.L., Arisi G.M., Katki K., Montafiez A., Sanchez R.M., Shapiro L.A. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus. J. Neuroinflammation 2009, 6:40.
36. Laing J.M., Aurelian L. Delta RR vaccination protects from KA-induced seizures and neuronal loss through ICP10PK-mediated modulation of the neuronal-microglial axis. Genet. Vaccines Ther. 2008, 6:1.
37. Lehtmakl K.A., Keranen T., Palmio J., Peltola J. Levels of IL-1 beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures. Neuromodulation 2010, 17(1):19-22.
38. Zhang S.J., Li X.W., Wei D., Jiang W. Expression of IL-1 mRNA in the dentate gyrus of adult rats following lithium-pilocarpine-induced seizures. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010, 26(3):288-290.
39. Pinteaux E., et al. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 2002, 83(4):754-763.
40. Belmadani A., et al. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci. 2006, 26(12):3182-3191.
41. Hesselgesser J., et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 1998, 8(10):595-598.
42. Vlahakis S.R., et al. G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. J. Immunol. 2002, 169(10):5546-5554.
43. Choi W.T., et al. Neuronal apoptotic signaling pathways probed and intervened by synthetically and modularly modified (SMM) chemokines. J. Biol. Chem. 2007, 282(10):7154-7163.
44. Jordan-Sciutto K.L., Murray Fenner B.A., Wiley C.A., Achim C.L. Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. Exp. Neurol. 2001, 167(2):205-214.
45. Phillips A.C., Ernst M.K., Bates S., Rice N.R., Vousden K.H. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell 1999, 4(5):771-781.
46. Vince J.E., Pantaki D., Feltham R., Mace P.D., Cordier S.M., Schmukle A.C., Davidson A.J., Callus B.A., Wong W.W., Gentle I.E., Carter H., Lee E.F., Walczak H., Day C.L., Vaux D.L., Silke J. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J. Biol. Chem. 2009, 284(51):35906-35915.
47. Sun B., Wingate H., Swisher S.G., Keyomarsi K., Hunt K.K. Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells. Cell Cycle 2010, 9(6).
48. Greene L.A., Biswas S.C., Liu D.X. Cell cycle molecules and vertebrate neuron death: E2F at the hub. Cell Death Differ. 2004, 11(1):49-60.
49. Chellappan S.P., et al. The E2F transcription factor is a cellular target for the RB protein. Cell 1991, 65(6):1053-1061.
50. Jordan-Sciutto K.L., et al. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am. J. Pathol. 2000, 157(2):497-507.
51. Shimizu S., Khan M.Z., Hippensteel R.L., Parkar A., Raghupathi R., Meucci O. Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology. Neurobiol. Dis. 2007, 25(1):17-26.
52. Engel T., Hatazaki S., Tanaka K., Prehn J.H., Henshall D.C. Deletion of Puma protects hippocampal neurons in a model of severe status epilepticus. Neuroscience 2010, 168(2):443-450.
53. Engel T., Murphy B.M., Hatazaki S., Jimenez-Mateos E.M., Concannon C.G., Woods I., Prehn J.H., Henshall D.C. Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J. 2010, 24(3):853-861.
54. Strachan G.D., et al. Chemokine- and neurotrophic factor-induced changes in E2F1 localization and phosphorylation of the retinoblastoma susceptibility gene product (pRb) occur by distinct mechanisms in murine cortical cultures. Exp. Neurol. 2005, 193(2):455-468.
55. Chu C.T., et al. Location, location, location: altered transcription factor trafficking in neurodegeneration. J. Neuropathol. Exp. Neurol. 2007, 66(10):873-883.
56. Murooka T.T., Wong M.M., Rahbar R., Majchrzak-Kita B., Proudfoot A.E., Fish E.N. CCL5-CCR5-mediated apoptosis in T cells: requirement for glycosaminoglycan binding and CCL5 aggregation. J. Biol. Chem. 2006, 281(35):25184-25194.
57. Ryu H.J., Kim J.E., Kim M.J., Kwon H.J., Suh S.W., Song H.K., Kang T.C. The protective effects of interleukin-18 and interferon-γ on neuronal damages in the rat hippocampus following status epilepticus. Neuroscience 2010, 170(3):711-721.
58. Goldstein K.R., Bhatt R., Barton B.E., Zalcman S.S., Rameshwar P., Siegel A. Effects of hemispheric lateralization and site specificity on immune alterations induced by kindled temporal lobe seizures. Brain Behav. Immun. 2002, 16(6):706-719.
59. Sharma V., Mishra M., Gosh S., Tewari R., Basu A., Seth P., Sen E. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res. Bull. 2007, 73(1-3):55-63.
60. Mocchetti I., Bachis A., Masliah E. Chemokine receptors and neurotrophic factors: potential therapy against aids dementia?. J. Neurosci. Res. 2008, 86(2):243-255.
61. Chvatchko Y., et al. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3. J. Immunol. 2003, 171(10):5498-5506.
62. Schroder C., et al. CCR5 blockade modulates inflammation and alloimmunity in primates. J. Immunol. 2007, 179(4):2289-2299.
63. Tompkins M.M., et al. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 1997, 150(1):119-131.
64. Patil K., Sharma S.C. Broad spectrum caspase inhibitor rescues retinal ganglion cells after ischemia. Neuroreport 2004, 15(6):981-984.
65. Wang Y., et al. E2F1 localizes predominantly to neuronal cytoplasm and fails to induce expression of its transcriptional targets in human immunodeficiency virus-induced neuronal damage. Neurosci. Lett. 2010, 479(2):97-101.
66. Boniha L., Yasuda C.L., Rorden C., Li L.M., Tedeschi H., de Oliveira E., Cendes F. Does resection of the medial temporal lobe improve the outcome of temporal lobe epilepsy surgery?. Epilepsia 2007, 48(3):571-578.
67. Cukiert A., Burattini J.A., Mariani P.P., Cukiert C.M., Argentoni M., Baise-Zung C., Forster C.R., Mello V.A. Outcome after cortico-amygdalo-hippocampectomy in patients with temporal lobe epilepsy and normal MRI. Seizure 2010, 19(6):319-323.
68. Murphy M., Smith P.D., Wood M., Bowden S., O'Brien T.J., Bulluss K.J., Cook M.J. Surgery for temporal lobe epilepsy associated with mesial temporal sclerosis in the older patient: a long-term follow-up. Epilepsia 2010, 51(6):1024-1029.